Evidence map›Paper›PMID 40764487›Full record

ArticleNature communications2025

Three positively charged binding sites on the eastern equine encephalitis virus E2 glycoprotein coordinate heparan sulfate- and protein receptor-dependent infection.

Maria D H Alcorn, Chengqun Sun, Theron C Gilliland, Tetyana Lukash, Christine M Crasto, Saravanan Raju, Michael S Diamond, Scott C Weaver, William B Klimstra

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Maria D H AlcornDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-8211-3647
Chengqun SunCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA.
Theron C GillilandCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA.
Tetyana LukashDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Christine M CrastoCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA.
Saravanan RajuDepartment of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Michael S DiamondDepartment of Medicine, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-8791-3165
Scott C WeaverInstitute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.ORCID http://orcid.org/0000-0001-8016-8556
William B KlimstraDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA. Klimstra@pitt.edu.ORCID http://orcid.org/0000-0003-4506-7842

Funding

Practices CoreUC7AI180311 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI William Paul Duprex · 2023 to 2026
$13.2M
Viral Persistence and PathogenesisT32AI049820 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELUCA, NEAL A. · 2001 to 2024
$5.5M
Molecular Mechanisms of Eastern Equine Encephalitis Virus PathogenesisR01AI095436 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2012 to 2022
$4.5M
LDLRAD3 Receptor Interaction with Venezuelan Equine Encephalitis VirusR01AI164653 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FREMONT, DAVED H. · 2021 to 2025
$3.8M
An Informed Approach to Live Attenuated Vaccines against Encephalitis AlphavirusesR01AI153209 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2020 to 2024
$2.9M
Building an atlas of B cell mediated protective immunity to alphavirusesK08AI187716 · NIAID · WASHINGTON UNIVERSITY · PI Saravanan Raju · 2025 to 2026
$340k
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) UC7AI180311NIAID NIH HHS K08 AI187716NIAID NIH HHS R01 AI095436NIAID NIH HHS R01 AI153209NIAID NIH HHS R01 AI164653NIAID NIH HHS T32 AI049820NIAID NIH HHS UC7 AI180311United States Department of Defense | Defense Threat Reduction Agency (DTRA) MCDC 2103-011
6 · The paper itself

Abstract

Naturally circulating strains of eastern equine encephalitis virus (EEEV) bind heparan sulfate (HS) receptors and this interaction has been linked to neurovirulence. Previous studies associated EEEV-HS interactions with three positively charged amino acid clusters on the E2 glycoprotein. One of these sites has recently been reported to be critical for binding EEEV to the very-low-density lipoprotein receptor (VLDLR), an EEEV receptor protein. The proteins apolipoprotein E receptor 2 (ApoER2) isoforms 1 and 2, and LDLR have also been shown to function as EEEV receptors. Herein, we investigate the individual contribution of each HS interaction site to EEEV HS- and protein receptor-dependent infection in vitro and EEEV replication in animals. We show that each site contributes to both EEEV-HS and EEEV-protein receptor interactions, providing evidence that altering these interactions can affect disease in mice and eliminate mosquito infectivity. Thus, multiple HS-binding sites exist in EEEV E2, and these sites overlap functionally with protein receptor interaction sites, with each type of interaction contributing to tissue infectivity and disease phenotypes.

Indexed as

Encephalitis Virus, Eastern EquineEncephalomyelitis, EquineHeparan SulfateReceptors, VirusViral Envelope ProteinsAnimalsBinding SitesFemaleHumansMiceProtein BindingReceptors, LDLVirus ReplicationHeparan SulfateReceptors, LDLReceptors, VirusViral Envelope Proteins

Identifiers

PMID40764487
PMCPMC12325700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.